| Literature DB >> 33408768 |
Javier Muñoz-Garcia1,2, Denis Cochonneau1, Stéphane Télétchéa3, Emilie Moranton1, Didier Lanoe1, Régis Brion4, Frédéric Lézot4, Marie-Françoise Heymann1, Dominique Heymann1,5.
Abstract
Macrophages are specialized cells that control tissue homeostasis. They include non-resident and tissue-resident macrophage populations which are characterized by the expression of particular cell surface markers and the secretion of molecules with a wide range of biological functions. The differentiation and polarization of macrophages relies on specific growth factors and their receptors. Macrophage-colony stimulating factor (CSF-1) and interleukine-34 (IL-34), also known as "twin" cytokines, are part of this regluatory landscape. CSF-1 and IL-34 share a common receptor, the macrophage-colony stimulating factor receptor (CSF-1R), which is activated in a similar way by both factors and turns on identical signaling pathways. However, there is some discrete differential activation leading to specific activities. In this review, we disscuss recent progress in understanding of the role of the twin cytokines in macrophage differentiation, from their interaction with CSF-1R and the activation of signaling pathways, to their implication in macrophage polarization of non-resident and tissue-resident macrophages. A special focus on IL-34, its involvement in pathophsyiological contexts, and its potential as a theranostic target for macrophage therapy will be proposed. © The author(s).Entities:
Keywords: IL-34; inflammation; macrophage differentiation; theranostics; tumor
Year: 2021 PMID: 33408768 PMCID: PMC7778581 DOI: 10.7150/thno.50683
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556